The Food and Drug Administration a public-private partnership to advance COVID-19 diagnostics.

鈥淲hile there are current studies of viral diagnostic and antibody tests using traditional assessment methods, the Diagnostics Evidence Accelerator will allow the community to analyze both diagnostic and clinical data in real time, which has the potential to contribute to the scientific evaluation of diagnostic tools and medical interventions for COVID-19,鈥 said FDA Principal Deputy Commissioner Amy Abernethy, M.D.

The project is a companion to a launched by the Udall Foundation for the FDA and Friends of Cancer Research in April, which brings together experts in health data aggregation and analytics to inform the collective COVID-19 response.

In other COVID-19 news this week, FDA to facilitate tracheal intubation and muscle relaxation during surgery or mechanical ventilation; and issued for marketing unauthorized test kits directly to consumers for at-home use.

Related News Articles

Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services. A鈥
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu鈥
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers鈥
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability鈥
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the鈥